Renin-Angiotensin Aldosterone System Inhipitors and COVID-19 A Systematic Review and Meta-Analysis Revealing Critical Bias Across a Body of Observational Research
BACKGROUND: Renin-angiotensin aldosterone system (RAAS) inhibitor-COVID-19 studies, observational in design, appear to use biased methods that can distort the interaction between RAAS inhibitor use and COVID-19 risk. This study assessed the extent of bias in that research and reevaluated RAAS inhibi...
Saved in:
Published in | Journal of the American Heart Association Vol. 11; no. 11 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
07.06.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!